Research Article

Assessing the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Stage I Non-Small-Cell Lung Cancer with Complete Resection

Table 2

Relationship between clinical, pathological, and NLR in postoperative stage I NSCLC patients.

VariablesNLow NLR (%)High NLR (%)χ2 value

Gender9.9790.002
 Male9770 (72.2)27 (27.8)
 Female9283 (90.2)9 (9.8)

Age at diagnosis (years)0.6250.429
 ≥656853 (77.9)15 (22.1)
 <65121100 (82.6)21 (17.4)

Smoking history3.1050.078
 Smoker7052 (74.3)18 (13.4)
 Nonsmoker118100 (84.7)18 (15.3)

Histologic type7.0640.029
 Squamous2617 (65.4)9 (34.6)
 Adenocarcinoma145123 (84.8)22 (15.2)
 Others128 (66.7)4 (33.3)

Stage4.2880.232
 IA11513 (86.7)2 (13.3)
 IA27968 (86.1)11 (13.9)
 IA34536 (80.0)9 (20.0)
 IB5036 (72.0)14 (28.0)

Differentiation2.3500.309
 Poor5138 (74.5)13 (25.5)
 Moderate3833 (86.8)5 (13.2)
 Well9679 (82.3)17 (17.7)

Chemotherapy0.0820.775
 Yes10989 (81.7)20 (18.3)
 No8064 (80.0)16 (20.0)

Visceral pleural invasion0.0010.980
 Absent163132 (81.0)31 (19.0)
 Present2621 (80.0)5 (19.2)

Lymphovascular invasion1.2360.266
 Absent150119 (79.3)31 (20.7)
 Present3934 (87.2)5 (12.8)

Recurrence2.6930.101
 Yes6750 (74.6)17 (25.4)
 No122103 (84.4)19 (15.6)

Survival15.9900.001
 Yes153130 (85.0)23 (15.0)
 No2412 (50.0)12 (50.0)